CSPC Pharmaceutical Group Ltd (CSPCY)
3.17
-0.05
(-1.55%)
USD |
OTCM |
Jun 21, 16:00
CSPC Pharmaceutical Group EPS Diluted (Quarterly): 0.0646 for Dec. 31, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0646 |
| September 30, 2023 | 0.0712 |
| June 30, 2023 | 0.074 |
| March 31, 2023 | 0.0701 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.0766 |
| September 30, 2022 | 0.0736 |
| June 30, 2022 | 0.0793 |
| March 31, 2022 | 0.0742 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
0.0646
Minimum
Dec 2023
0.0793
Maximum
Jun 2022
0.0729
Average
0.0738
Median
EPS Diluted (Quarterly) Benchmarks
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | -0.71 |
| Zai Lab Ltd | -0.50 |
| Adagene Inc | -- |
| LakeShore Biopharma Co Ltd | -0.1565 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 191.54M |
| Revenue (Quarterly) | 1.054B |
| Total Expenses (Quarterly) | 805.15M |
| Enterprise Value | 7.900B |
| Gross Profit Margin (Quarterly) | 70.99% |
| Profit Margin (Quarterly) | 18.18% |
| Earnings Yield | 8.83% |
| Operating Earnings Yield | 10.54% |
| Normalized Earnings Yield | 8.828 |